Consumer Settlement · Payments Reported

Similasan Eye Drop Settlement Payments Sent

Published February 25, 2026
Updated August 4, 2026

The $3.575 million Similasan eye-drop settlement is closed to new claims. Payments were reported beginning in February 2026, while the official site continues to accept documentation only from claimants sent a deficiency notice.

Similasan eye drop settlement payment update

What Is the Current Similasan Settlement Status?

The settlement received final approval in July 2025, and the October 15, 2025 claim deadline has passed. Payment reports began in late February 2026. The official site now directs only people who received a deficiency notice to cure the identified problem; it does not reopen the claim period.

Status Payments reported Distribution began in February 2026
Claim Deadline October 15, 2025 Closed to new claims
Settlement Fund $3.575 million Plowden et al. v. Similasan Corp.

What Did the Lawsuit Allege?

Consumers alleged that covered Similasan, CVS, and Walgreens homeopathic eye products were deceptively labeled and advertised, including claims involving regulatory status and manufacturing practices. Similasan denied wrongdoing and settled without admitting liability.

How Were Awards Calculated?

The agreement provided $2.50 per covered product. Claims without qualifying proof were capped at four products, or $10 per household. Claims with valid proof could include additional products. Final payments were subject to the settlement’s pro-rata rules and claim review.

Which Products Were Covered?

The settlement included identified Similasan eye-relief products and certain CVS and Walgreens private-label eye drops supplied by Similasan. The court-approved notice contains the controlling product list and class period.

What Should Claimants Do About a Deficiency Notice?

A claimant who received a deficiency notice should use the cure portal linked from the official settlement website and provide only the requested documentation. New claimants cannot use that portal to enter the closed settlement.

Sources

Official Similasan Eye Relief Settlement website
Settlement agreement and award terms
Detailed settlement eligibility and status


For more class actions keep scrolling below.
Status Claims closed; payments reported
Settlement Fund $3.575 million
Case Plowden et al. v. Similasan Corp.
Claim Deadline October 15, 2025

More Consumer and Legal Updates